C1 Esterase Inhibitor Subcutaneous Market: Robust Growth Driven by...

a adăugat un sunet Wellness

2026-07-31 09:06:32 -

C1 Esterase Inhibitor Subcutaneous Market: Robust Growth Driven by Hereditary Angioedema Treatment Demand, Self-Administration Convenience, and Advancing Rare Disease Therapeutics

The C1 Esterase Inhibitor Subcutaneous Market is experiencing robust growth as demand for hereditary angioedema (HAE) treatments increases, self-administration convenience becomes a priority, and rare disease therapeutics continue to advance. The global market was valued at approximately USD 1.2–1.8 billion in 2024–2025 and is projected to reach around USD 2.5–3.0 billion by...

0 Commentarii 0 Distribuiri 630 Views 0 previzualizare